Agilent Technologies Inc at Evercore HealthCONx Conference Transcript
Okay. Thanks, everyone, for joining us this morning. A pleasure to have Agilent with us this morning. Representing the company, we have CFO Bob McMahon. From the IR team, we have Ruben DiRado. Thank you both for coming.
For those of you who don't know me, I'm Vijay Kumar. I cover life science tools now as well as devices. It's been an interesting start to tools, where -- and I have to say Agilent has made my life a little easier here getting -- easing into 3Q. So thank you for that.
It's our job.
Questions & Answers
So Bob, maybe just -- well, I guess, this was your fiscal 4Q. Solid start -- finish to '19. Q4 came in above. One of the comments that caught my attention was CrossLabs. Because services, when I look at across tools, like everyone talks about services and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |